$0.5350
0.002950.55%
Last update: Nov 6, 1:41 PM
Lantern Pharma Inc
LTRNNASDAQ
The average analyst price target for Lantern Pharma is $25, 4573.3% above the current price. Of 2 analysts, 1 rates it Buy and 1 Hold. The latest change came on Apr 2, 2025, when Lake Street initiated coverage of Lantern Pharma with a Buy rating and a $25 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months
